FHN:NYSEFirst Horizon Corporation Analysis
Data as of 2026-06-18 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
First Horizon (FHN) is trading at $24.81, comfortably above its 20‑day SMA of $24.40 and the 50‑day SMA of $24.36, while still below the 200‑day SMA of $23.37, indicating a short‑term bullish bias with momentum supported by a bullish MACD histogram (+0.056) and a neutral RSI (56). The stock sits just above the calculated support level of $23.47 and has room to climb toward resistance at $25.42, with volume trending upward, reinforcing the technical upside. The Fear & Greed Index sits at 92.14 (“Extreme Greed”), suggesting strong market enthusiasm. Fundamentally, FHN trades at a forward P/E of 10.56 versus an industry average of 16.90, offering a valuation edge, and its dividend yield of 2.73% with a modest 31% payout ratio appears sustainable given positive operating cash flow. Revenue growth of 9.7% and an ROE of 11.3% underscore solid earnings momentum, while the upside potential of roughly 8% (DCF fair value $14.20 versus current price) points to modest upside. The balance sheet shows $4.9 B in cash against $5.9 B of debt, leaving a manageable net debt position. Recent material news highlights the bank’s second VETS Indexes Employer award and an expanded financial‑literacy program, reinforcing its community and ESG credentials. Despite a 1.1% post‑earnings dip that lagged the S&P 500, the combination of bullish technical signals, attractive valuation relative to peers, and a stable dividend supports a positive outlook.
Market Outlook
Short Term
< 1 yearKey Factors
- Bullish MACD and rising volume
- Price above key support level
- Recent earnings dip but no fundamental deterioration
Medium Term
1–3 yearsKey Factors
- Forward P/E well below industry average
- Sustainable 2.73% dividend yield
- Revenue growth near 10% and solid ROE
Long Term
> 3 yearsKey Factors
- Stable dividend and cash flow generation
- Moderate leverage with net‑debt position
- Sector cyclicality and regulatory environment
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.